CD79A and nasopharyngeal carcinoma: In view of the obvious explicitness of the connection between the degrees of IgA of VCA and NPC, a mass serological location program in the city of Wuzhou, China was conducted in 1980, where it was shown that EBV-explicit antibodies are valuable for NPC’s initial distinguishing proof [35].